Confined or spread disease-Spread with distant metastasis - Page 18 of 24 Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread with distant metastasis Posts on Medivizor

Comparison of two biologic drugs for treating metastatic colorectal cancer

Comparison of two biologic drugs for treating metastatic colorectal cancer

Posted by on Apr 6, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared two biologic drugs (drugs extracted from biological sources) for treating metastatic (spread to other areas of the body) colorectal cancer. Some background Metastatic colorectal cancer is often treated with combinations of chemotherapy drugs. One common combination is called FOLFIRI, and includes the agents...

Read More

What is recommended for patients with HER2 positive cancer that has spread to the brain?

What is recommended for patients with HER2 positive cancer that has spread to the brain?

Posted by on Mar 9, 2015 in Breast cancer | 0 comments

In a nutshell This paper gave recommendations for treating patients with human epidermal growth factor receptor 2- positive (presence of HER2 on cancer cells) breast cancer that has spread to the brain.   Some background Some patients have breast cancer where human epidermal growth factor receptor 2 (HER2, a protein) is present. With...

Read More

Chemotherapy plus bevacizumab (Avastin) for metastatic colorectal cancer. Which is the best combination?

Chemotherapy plus bevacizumab (Avastin) for metastatic colorectal cancer. Which is the best combination?

Posted by on Mar 2, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared two strategies for treating patients with metastatic colorectal cancer (colorectal cancer that has spread to distant sites). Some background Bevacizumab is an anti-cancer drug that blocks the formation of new blood vessels needed for the cancer to grow and spread. Combined with chemotherapy it is a standard first...

Read More

MiR-31-5p: a tiny little messenger that could predict if treatment will benefit colorectal cancer patients

MiR-31-5p: a tiny little messenger that could predict if treatment will benefit colorectal cancer patients

Posted by on Jan 25, 2015 in Colorectal cancer | 0 comments

In a nutshell This study evaluated whether specific microRNA expression was predictive of anti-epidermal growth factor receptor (anti-EGFR) treatment success in patients with metastatic colorectal cancer (late stage cancer that has spread to distant sites). Some background MicroRNA’s are small messengers that help to regulate expression of...

Read More

Vemurafenib – a safe and effective treatment option for BRAFV600 mutated melanoma patients

Posted by on Jan 15, 2015 in Melanoma | 0 comments

In a nutshell The authors aimed to determine the safety profile of vemurafenib in patients with  BRAFV600 mutated metastatic melanoma with few treatment options remaining. Some background BRAF (protein in the body that controls cell growth) mutations are one of the key factors that lead to melanoma development. In particular, BRAFV600 (a...

Read More

Possible new treatment plan for colorectal cancer patients with liver metastases

Possible new treatment plan for colorectal cancer patients with liver metastases

Posted by on Dec 15, 2014 in Colorectal cancer | 0 comments

In a nutshell This study investigated the benefits of combination drug therapy (mFOLFOX6 and bevacizumab) for patients with colorectal cancer that has spread to the liver (liver metastases).  Some background The 5-year survival rate is lower for colorectal cancer patients if the cancer has spread (metastasized) to other organs (stage IV). In...

Read More

Can certain factors predict survival in colorectal cancer that has spread to the lungs?

Can certain factors predict survival in colorectal cancer that has spread to the lungs?

Posted by on Oct 5, 2014 in Colorectal cancer | 0 comments

In a nutshell The authors aimed to investigate factors associated with survival when undergoing surgery to remove colorectal cancer metastases in the lungs. Some background Metastatic colorectal cancer is cancer that has spread from the original site (in the colon or rectum) to distant organs. Chemotherapy can prolong average survival times and...

Read More